Xeris Biopharma Holdings, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of XERS for the last quarter is 44.39 M USD, and it's 8.13% lower compared to the previous quarter. The net income of Q4 23 is -13.39 M USD.